Literature DB >> 17594133

Results of an intervention for individuals and families with BRCA mutations: a model for providing medical updates and psychosocial support following genetic testing.

Wendy McKinnon1, Shelly Naud, Taka Ashikaga, Rose Colletti, Marie Wood.   

Abstract

: Providing medical management updates and long-term support to families with hereditary cancer syndromes in rural areas is a challenge. To address this, we designed a one-day retreat for BRCA1/2 carriers in our region. The retreat included educational updates about medical management, genetic privacy and discrimination, and addressed psychological and family issues. Evaluations completed at the conclusion of the retreat were overwhelmingly positive with requests for a similar event in the future. The impact of this retreat on a variety of health behaviors was assessed. Eligible participants completed questionnaires before and 6 months after the retreat. Questionnaires focused on lifestyle, cancer screening and prevention practices, psychological history and distress, decision-making regarding genetic testing, and family communication issues. For individuals who completed both the pre and post retreat questionnaires, one-half made lifestyle changes and nearly two-thirds increased cancer screening, initiated chemoprevention, completed or planned to complete preventative surgery in the future. We conclude that this type of forum provides a valuable opportunity for BRCA carriers and their families to receive updated medical information, share personal experiences, provide and receive support, as well as change health behaviors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17594133     DOI: 10.1007/s10897-006-9078-8

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  42 in total

1.  Support groups for people carrying a BRCA mutation.

Authors:  M Dorval; E Maunsell; M J Dugas; J Simard
Journal:  CMAJ       Date:  2001-09-18       Impact factor: 8.262

2.  Factors associated with decisions about clinical BRCA1/2 testing.

Authors:  K Armstrong; K Calzone; J Stopfer; G Fitzgerald; J Coyne; B Weber
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-11       Impact factor: 4.254

Review 3.  Genetic testing for breast and ovarian cancer susceptibility: a family experience.

Authors:  Marcia Van Riper; Wendy C McKinnon
Journal:  J Midwifery Womens Health       Date:  2004 May-Jun       Impact factor: 2.388

4.  Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer.

Authors:  B Thewes; B Meiser; I B Hickie
Journal:  Psychooncology       Date:  2001 Nov-Dec       Impact factor: 3.894

5.  Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.

Authors:  L Wideroff; S T Vadaparampil; M H Greene; S Taplin; L Olson; A N Freedman
Journal:  J Med Genet       Date:  2005-03-22       Impact factor: 6.318

6.  BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.

Authors:  Aideen McInerney-Leo; Barbara Bowles Biesecker; Donald W Hadley; Ronald G Kase; Therese R Giambarresi; Elizabeth Johnson; Caryn Lerman; Jeffery P Struewing
Journal:  Am J Med Genet A       Date:  2005-03-01       Impact factor: 2.802

7.  Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.

Authors:  C Lerman; B Biesecker; J L Benkendorf; J Kerner; A Gomez-Caminero; C Hughes; M M Reed
Journal:  J Natl Cancer Inst       Date:  1997-01-15       Impact factor: 13.506

8.  Family issues in a psychoeducation group for women with a BRCA mutation.

Authors:  J Speice; S H McDaniel; P T Rowley; S Loader
Journal:  Clin Genet       Date:  2002-08       Impact factor: 4.438

9.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D F Easton; D Ford; D T Bishop
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

10.  A consultation with Canadian rural women with breast cancer.

Authors:  Ross E Gray; Pamela James; Jackie Manthorne; Judy Gould; Margaret I Fitch
Journal:  Health Expect       Date:  2004-03       Impact factor: 3.377

View more
  23 in total

1.  A multidisciplinary clinic for individualizing management of patients at increased risk for breast and gynecologic cancer.

Authors:  Natalie J Engel; Patricia Gordon; Darcy L Thull; Beth Dudley; Judy Herstine; Rachel C Jankowitz; Kristin K Zorn
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

2.  Are family-oriented interventions in Portuguese genetics services a remote possibility? Professionals' views on a multifamily intervention for cancer susceptibility families.

Authors:  Alvaro Mendes; Milena Paneque; Liliana Sousa
Journal:  J Community Genet       Date:  2012-02-08

Review 3.  Factors influencing intrafamilial communication of hereditary breast and ovarian cancer genetic information.

Authors:  Gillian Nycum; Denise Avard; Bartha M Knoppers
Journal:  Eur J Hum Genet       Date:  2009-03-25       Impact factor: 4.246

4.  Closing the loop: action research in a multimodal hereditary cancer patient conference is an effective tool to assess and address patient needs.

Authors:  Carin R Espenschied; Deborah J MacDonald; Julie O Culver; Sharon Sand; Karen Hurley; Kimberly C Banks; Jeffrey N Weitzel; Kathleen R Blazer
Journal:  J Cancer Educ       Date:  2012-06       Impact factor: 2.037

5.  Educational and Psychosocial Support Needs in Lynch Syndrome: Implementation and Assessment of an Educational Workshop and Support Group.

Authors:  Marina J Corines; Jada G Hamilton; Emily Glogowski; Chris A Anrig; Rachael Goldberg; Kate Niehaus; Erin Salo-Mullen; Megan Harlan; Margaret R Sheehan; Magan Trottier; Asad Ahsraf; Christina Tran; Lauren Jacobs; Rohini Rau-Murthy; Anne G Lincoln; Mark E Robson; Jose G Guillem; Arnold J Markowitz; Kenneth Offit; Zsofia K Stadler
Journal:  J Genet Couns       Date:  2016-10-12       Impact factor: 2.537

6.  Disclosure pattern and follow-up after the molecular diagnosis of BRCA/CHEK2 mutations.

Authors:  D Kegelaers; W Merckx; P Odeurs; J van den Ende; B Blaumeiser
Journal:  J Genet Couns       Date:  2013-10-11       Impact factor: 2.537

7.  An iPhone Application Intervention to Promote Surveillance Among Women with a BRCA Mutation: Pre-intervention Data.

Authors:  Stephanie A Cohen; Courtney Lynam Scherr; Dawn M Nixon
Journal:  J Genet Couns       Date:  2018-02-10       Impact factor: 2.537

8.  Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial.

Authors:  Susan V Montgomery; Andrea M Barsevick; Brian L Egleston; Ruth Bingler; Karen Ruth; Suzanne M Miller; John Malick; Terrence P Cescon; Mary B Daly
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

9.  Cancer genetic counselees' self-reported psychological distress, changes in life, and adherence to recommended surveillance programs 3-7 years post counseling.

Authors:  Afsaneh Hayat Roshanai; Richard Rosenquist; Claudia Lampic; Karin Nordin
Journal:  J Genet Couns       Date:  2009-02-11       Impact factor: 2.537

10.  A family genetic risk communication framework: guiding tool development in genetics health services.

Authors:  Miriam E Wiens; Brenda J Wilson; Christina Honeywell; Holly Etchegary
Journal:  J Community Genet       Date:  2013-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.